NCT06501118 Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
| NCT ID | NCT06501118 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Respiratory Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,600 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2026-07-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,600 participants in total. It began in 2024-09-01 with a primary completion date of 2026-07-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A multimodal educational intervention to target an oxygen saturation target range (SpO2 90-96%) will reduce ventilator length of stay and reduce occult hypoxemia by increased awareness and adherence to a designated oxygen saturation target range.
Eligibility Criteria
Inclusion Criteria: * Admission to ICU and requiring invasive mechanical ventilation Exclusion Criteria: * Transferred patients from outside the UCHealth system\*: * Patients with pre-existing disease that requires chronic use of positive pressure ventilation delivered through a tracheostomy\*: * Pregnant women: * Prisoners * Patients receiving mechanical ventilation for less than twelve hours
Contact & Investigator
Neil Aggarwal, MD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT06501118 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Respiratory Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06501118 currently recruiting?
Yes, NCT06501118 is actively recruiting participants. Contact the research team at carrie.higgins@cuanschutz.edu for enrollment information.
Where is the NCT06501118 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT06501118 clinical trial?
NCT06501118 is sponsored by University of Colorado, Denver. The principal investigator is Neil Aggarwal, MD at University of Colorado, Denver. The trial plans to enroll 3,600 participants.